human
astroviru
hastv
member
astrovirida
famili
small
nm
nonenvelop
viru
positivesens
rna
genom
bound
end
viral
protein
vpg
polyadenyl
end
human
astrovirus
caus
gastroenter
lead
caus
viral
diarrhea
young
children
hastv
type
preval
eight
known
hastv
serotyp
patient
gastroenter
viral
genom
encod
two
nonstructur
protein
structur
protein
viral
capsid
protein
protein
encod
open
read
frame
orf
wherea
produc
translat
frameshift
mechan
begin
translat
skip
stop
codon
shift
overlap
polyprotein
catalyz
proteolyt
process
produc
function
viral
protein
includ
vpg
rnadepend
rna
polymeras
viral
protein
believ
concertedli
modul
cellular
function
facilit
viral
propag
directli
particip
viral
rna
replic
viral
capsid
protein
encod
translat
protein
undergo
matur
process
cellular
enzym
trypsin
becom
function
viral
capsid
progeni
virion
produc
host
cell
releas
without
cell
lysi
appear
link
process
viral
capsid
protein
cellular
caspas
may
involv
cellular
apoptot
event
mani
viral
infect
known
activ
host
cell
signal
pathway
initi
contact
virus
host
cell
trigger
seri
signal
cascad
facilit
viral
entri
viral
propag
within
cell
specif
virusinduc
signal
may
activ
cellular
mechan
virus
reli
initi
infect
endocytosi
macrocytosi
phagocytosi
well
mobil
actin
cytoskeleton
one
import
cellular
signal
pathway
phosphoinositid
akt
pathway
regul
divers
cellular
activ
includ
cell
growth
prolifer
surviv
apoptosi
metabol
migrat
vesicular
traffick
activ
src
homolog
domain
regulatori
subunit
bind
autophosphoryl
tyrosin
kinas
receptor
nonreceptor
tyrosin
kinas
viral
protein
cytoplasm
catalyt
subunit
activ
convert
phosphatidylinositol
lipid
messeng
phosphatidylinositol
trisphosph
activ
downstream
target
primari
target
akt
serinethreonin
protein
kinas
modul
divers
signal
pathway
cell
surviv
prolifer
migrat
differenti
apoptosi
bind
allow
akt
form
complex
phosphoryl
activ
akt
anoth
import
target
small
gprotein
involv
cytoskelet
remodel
lamellipodium
format
celltocel
contact
cell
migrat
activ
mediat
activ
guanin
exchang
factor
tlymphoma
invas
metastasi
actor
anoth
import
group
cellular
signal
pathway
mitogenactiv
protein
kinas
mapk
includ
extracellular
signalregul
kinas
cjun
ntermin
kinas
jnk
pathway
signal
transduc
activ
receptor
tyrosin
kinas
small
g
protein
ra
raf
mapkerk
activ
phosphoryl
activ
known
regul
cell
surviv
prolifer
differenti
intracellular
signal
event
control
infect
still
well
understood
studi
moser
schultzcherri
found
activ
initi
contact
hastv
host
cell
import
establish
hastv
infect
studi
sought
identifi
addit
signal
pathway
play
import
role
infect
approach
use
panel
kinas
inhibitor
test
whether
specif
inhibit
individu
signal
pathway
interfer
infect
found
inhibitor
activ
block
infect
despit
fact
erk
activ
inhibit
activ
occur
earli
phase
infect
appar
involv
phosphoryl
akt
thu
result
reveal
previous
unknown
role
infect
search
signal
pathway
import
infect
examin
variou
kinas
blocker
inhibitor
tabl
abil
block
infect
cell
cell
infect
presenc
absenc
kinas
inhibitor
presenc
inhibitor
maintain
hour
postinfect
hpi
cell
detect
viral
capsid
protein
immunofluoresc
dmso
solvent
inhibitor
interfer
viral
gene
express
figur
panel
staurosporin
figur
b
b
gener
kinas
inhibitor
genistein
figur
c
c
gener
inhibitor
tyrosin
kinas
block
viral
gene
express
note
staurosporin
treatment
caus
modest
cellular
toxic
evid
nuclear
stain
dapi
figur
b
colorimetr
assay
cell
viabil
figur
howev
almost
complet
absenc
cell
posit
viral
antigen
suggest
drug
effect
block
infect
cell
surviv
drug
treatment
consist
previous
report
requir
signal
infect
inhibitor
block
phosphoryl
also
block
viral
gene
express
figur
member
mapk
famili
test
appear
involv
establish
infect
neither
sb
block
activ
figur
e
e
jnk
inhibitor
ii
select
inhibit
jnk
figur
f
f
signific
effect
viral
capsid
gene
express
also
abl
confirm
activ
occur
earli
stage
infect
phosphoryl
level
variou
kinas
examin
differ
time
postinfect
western
blot
phosphoryl
phosphorylationindepend
epitop
kinas
figur
signal
intens
band
rel
mockinfect
sampl
hpi
present
figur
compar
mockinfect
sampl
phosphoryl
level
notic
elev
earli
time
point
hpi
hpi
figur
perk
figur
erk
similarli
phosphoryl
level
appear
elev
hpi
figur
figur
margin
increas
phosphoryl
level
jnk
observ
infect
cell
throughout
time
point
examin
figur
pjnk
figur
jnk
howev
phosphoryl
jnk
necessari
infect
judg
result
capsid
protein
express
assay
perform
inhibitor
specif
kinas
figur
note
level
phosphoryl
increas
hpi
figur
right
perk
observ
report
earlier
unlik
relat
infect
event
phosphoryl
similarli
elev
time
point
mockinfect
sampl
left
perk
panel
search
addit
infectionrel
signal
pathway
uncov
evid
import
activ
inhibitor
figur
panel
effect
block
postinfect
viral
capsid
express
wherea
inhibitor
wortmannin
figur
panel
b
b
slightli
less
effect
evidenc
unusu
punctat
signal
capsid
protein
possibl
explan
although
potent
inhibit
activ
wortmannin
stabl
minut
cellular
environ
make
effect
appar
treatment
last
h
one
possibl
consist
observ
effect
inhibitor
infect
may
led
inhibit
erk
phosphoryl
map
kinas
pathway
known
crosstalk
small
gtpase
ra
evalu
possibl
phosphoryl
level
erk
presenc
absenc
blocker
analyz
western
blot
figur
found
unlik
abolish
postinfect
erk
phosphoryl
figur
perk
panel
group
affect
phosphoryl
figur
perk
panel
group
thu
inhibitor
exert
effect
interfer
erk
activ
act
distinct
essenti
process
infect
ask
whether
known
downstream
target
signal
akt
play
role
infect
consist
activ
viral
infect
akt
target
activ
extent
akt
phosphoryl
greater
h
h
postinfect
sampl
correspond
mockinfect
control
figur
pakt
figur
akt
howev
treatment
triciribin
figur
c
c
figur
known
inhibit
akt
activ
well
aktmedi
phosphoryl
margin
effect
viral
capsid
express
examin
phosphoryl
level
akt
cell
incub
wortmannin
triciribin
h
show
triciribin
treatment
effect
block
phosphoryl
akt
addit
file
see
discuss
addit
aktmedi
cascad
also
known
target
activ
block
inhibitor
gef
interfer
infect
figur
e
e
also
test
involv
signal
cascad
block
activ
protein
kinas
pka
compet
atp
bind
site
pka
catalyt
subunit
inhibit
rhoassoci
protein
kinas
rock
neither
inhibitor
respect
inhibitori
effect
viral
capsid
protein
express
figur
g
g
f
f
indic
neither
pka
rhomedi
pathway
signific
gene
express
increas
akt
activ
h
postinfect
suggest
activ
occur
earli
stage
infect
also
note
increas
akt
phosphoryl
hpi
examin
activ
need
initi
phase
infect
inhibitor
akt
ad
hpi
proport
cell
posit
viral
capsid
express
examin
immunofluoresc
figur
inhibitor
block
viral
gene
express
time
point
inhibitor
wortmannin
effect
diminish
viral
gene
express
ad
hpi
time
rang
effect
similar
erk
inhibitor
neither
inhibitor
effect
hpi
although
triciribinetr
cell
appear
exhibit
lower
proport
infect
cell
differ
control
sampl
signific
akt
inhibitor
affect
viral
gene
express
figur
suggest
blockad
akt
littl
effect
infect
nonetheless
result
show
blockad
infect
inhibitor
ad
hpi
consist
increas
phosphoryl
akt
min
postinfect
seen
western
blot
figur
mark
increas
kinas
activ
earli
time
point
suggest
activ
import
initi
stage
infect
immunofluoresc
detect
viral
capsid
protein
offer
qualit
indic
whether
given
kinas
inhibitor
affect
initi
infect
process
lead
viral
gene
express
order
quantit
measur
effect
drug
viral
propag
amount
viral
rna
produc
cell
hpi
presenc
absenc
drug
measur
quantit
realtim
rtpcr
figur
cell
treat
genistein
staurosporin
contain
significantli
lower
amount
viral
rna
cell
treat
solvent
alon
consist
find
drug
inhibitori
express
viral
capsid
although
treatment
wortmannin
could
show
inhibitori
effect
viral
capsid
express
figur
translat
signific
effect
viral
rna
replic
see
discuss
surprisingli
drug
inhibit
viral
gene
mapk
jnk
jnk
inhibitor
ii
akt
pka
measur
effect
extent
viral
rna
replic
treatment
triciribin
induc
higher
level
rna
replic
inhibit
product
viral
rna
result
support
idea
activ
import
initi
viral
infect
via
nonakt
nonrac
mediat
pathway
next
examin
effect
kinas
inhibitor
releas
viral
rna
indic
virion
releas
cell
measur
level
viral
rna
present
cultur
supernat
cell
hpi
figur
agreement
result
viral
rna
replic
analysi
treatment
staurosporin
genistein
greatli
reduc
amount
viral
rna
detect
supernat
wortmannin
treatment
also
lower
viral
rna
content
supernat
akt
inhibitor
triciribin
exhibit
contrast
effect
triciribin
appar
increas
amount
viral
rna
cultur
supernat
well
extent
viral
rna
replic
figur
b
wherea
margin
effect
viral
rna
accumul
cell
cultur
supernat
inhibitor
rock
respect
similarli
fail
reduc
either
viral
rna
replic
viral
rna
releas
cultur
supernat
consist
inabl
prevent
viral
gene
express
howev
pka
inhibitor
show
inhibitori
effect
extracellular
viral
rna
accumul
suggest
pka
may
play
role
viru
releas
cell
test
effect
kinas
inhibitor
anoth
marker
viru
product
releas
presenc
viral
capsid
cultur
supernat
infect
cell
hpi
figur
result
larg
consist
analysi
viral
rna
presenc
cultur
supernat
figur
drug
inhibit
viral
capsid
staurosporin
inhibit
viral
capsid
accumul
cultur
supernat
wortmannin
similarli
lower
level
extracellular
capsid
protein
consist
lower
extracellular
viral
rna
figur
wortmannin
contrast
effect
akt
inhibitor
triciribin
seen
assay
intracellular
viral
rna
product
extracellular
viral
rna
presenc
also
detect
product
extracellular
viral
capsid
rock
inhibitor
effect
pka
inhibitor
show
inhibitori
effect
extracellular
viral
capsid
product
agreement
respect
effect
viral
rna
figur
studi
panel
kinas
inhibitor
use
identifi
cellular
signal
transduct
pathway
import
infect
found
inhibitor
activ
interf
infect
independ
erk
activ
show
activ
occur
earli
phase
infect
downstream
target
akt
requir
infect
block
either
wortmannin
diminish
product
viral
particl
indic
activ
import
infect
addit
pka
involv
aspect
viral
particl
product
taken
togeth
result
reveal
previous
unknown
role
establish
infect
pka
viral
product
data
indic
earli
min
virion
contact
host
cell
activ
signal
cascad
involv
treat
cell
inhibitor
result
block
infect
detect
level
viral
gene
express
viral
rna
replic
releas
viral
capsid
rna
cell
although
phosphoryl
akt
appear
essenti
viral
infect
earli
time
frame
activ
indic
activ
earli
phase
infect
perhap
step
viral
entri
similarli
erk
activ
shown
import
earli
infect
thu
erk
signal
appear
function
earli
phase
infect
viral
cell
entri
initi
viral
gene
express
cours
studi
also
found
pka
inhibitor
decreas
releas
viral
compon
cultur
supernat
block
capsid
protein
express
viral
rna
replic
recent
analysi
human
cytomegaloviru
infect
use
kinom
profil
show
pka
cascad
involv
product
progeni
virion
regul
metabol
pathway
host
cell
would
interest
examin
whether
pka
cascad
metabol
control
product
among
mapk
pathway
found
erk
phosphoryl
shortli
virion
make
contact
cell
activ
erk
appear
essenti
infect
inhibit
erk
activ
block
infect
inhibit
sb
similarli
akt
one
major
downstream
target
found
phosphoryl
earli
infect
though
inhibitor
akt
triciribin
seem
block
viral
capsid
express
viral
rna
replic
viral
compon
releas
henc
activ
akt
pathway
upon
infect
appear
either
nonessenti
infect
redund
pathway
could
relay
essenti
signal
infecti
process
interest
note
wortmannin
treatment
show
blockad
rna
replic
exhibit
block
viral
releas
immunofluoresc
detect
viral
capsid
protein
reveal
treatment
wortmannin
caus
unusu
punctat
stain
capsid
protein
suggest
reagent
fail
block
viral
entri
effect
delay
process
lead
capsid
express
show
aberr
distribut
time
point
examin
viral
rna
replic
hpi
may
point
viral
rna
replic
alreadi
reach
plateau
inhibitori
effect
wortmannin
releas
rna
virion
may
visibl
delay
infecti
process
treatment
triciribin
enhanc
viral
rna
replic
cell
possibl
caus
increas
viral
releas
infer
level
viral
rna
capsid
protein
cultur
supernat
figur
surprisingli
found
akt
phosphoryl
effect
block
hpi
addit
file
viral
capsid
releas
enhanc
dosedepend
manner
addit
file
also
note
triciribin
treatment
slightli
enhanc
cell
viabil
figur
overal
treatment
appear
posit
effect
viral
propag
experi
rather
inhibitori
effect
similarli
treatment
increas
extent
viral
rna
replic
interestingli
mark
increas
phosphoryl
akt
level
observ
cell
treat
drug
addit
file
akt
activ
known
involv
feedback
loop
activ
led
rock
inhibit
use
rhofamili
signal
event
known
involv
balanc
regul
inhibit
anoth
member
rhofamili
could
also
activ
feedback
loop
activ
akt
possibl
caus
increas
protein
synthesi
could
enhanc
viral
rna
replic
note
two
akt
phosphoryl
inhibitor
affect
infect
differ
triciribin
appar
increas
amount
viral
rna
releas
viral
rna
capsid
cultur
supernat
wherea
figur
differ
could
due
differ
drug
inhibitori
mechan
triciribin
inhibit
akt
phosphoryl
bind
ph
domain
akt
therebi
block
recruit
plasma
membran
wherea
bind
catalyt
domain
akt
inhibit
phosphoryl
triciribin
also
known
inhibit
cellular
dna
synthesi
nonetheless
neither
akt
inhibitor
block
viral
infect
summari
studi
reveal
two
signal
pathway
mediat
erk
import
infect
observ
specif
select
kinas
inhibitor
block
erk
phosphoryl
yet
exhibit
inhibitori
effect
infect
indic
cascad
act
independ
downstream
mediat
erk
figur
involv
erk
activ
uncommon
signal
viral
infect
erk
signal
shown
import
mobil
receptor
hepat
c
viru
hcv
viral
gene
express
respiratori
syncyti
viru
human
cytomegaloviru
kaposi
sarcomaassoci
herp
viru
kshv
viral
genom
replic
influenza
viru
mous
hepat
viru
viral
assembl
hcv
viral
releas
host
cell
borna
diseas
viru
similarli
activ
need
viral
entri
influenza
viru
avian
leucosi
retroviru
vaccinia
viru
also
function
depend
akt
activ
unlik
case
infect
integr
multipl
signal
cascad
shown
kshv
infect
cascad
involv
viral
earli
gene
express
cascad
erk
activ
import
viral
entri
integr
erk
pathway
observ
infect
rather
signal
pathway
appear
separ
pattern
kinas
activ
infect
found
virus
studi
uncov
uniqu
signal
transduct
strategi
establish
infect
host
cell
panel
kinas
inhibitor
use
identifi
cellular
signal
transduct
pathway
import
infect
inhibitor
block
activ
found
interfer
infect
independ
process
erk
activ
activ
occur
earli
phase
infect
downstream
target
requir
infect
akt
moreov
pka
found
involv
aspect
viral
particl
product
result
reveal
previous
unknown
role
establish
infect
pka
viral
product
isol
provid
dr
mitsuaki
oseto
ehim
hygien
environment
institut
japan
cell
dr
naomi
sakon
osaka
prefectur
institut
public
health
origin
given
dr
albert
z
kapikian
maintain
cultur
medium
emem
consist
minimum
essenti
medium
eagl
modif
emem
catalog
sigmaaldrich
st
loui
mo
usa
supplement
mm
sodium
pyruv
nonessenti
amino
acid
invitrogen
green
island
ny
usa
fetal
bovin
serum
prepar
stock
cell
infect
approxim
viral
particl
per
cell
cultur
supernat
collect
day
infect
freezethaw
clear
cell
debri
centrifug
store
aliquot
stock
stock
typic
contain
particl
per
ml
number
viral
particl
present
viral
prepar
determin
measur
rna
copi
number
obtain
use
realtim
quantit
rtpcr
viral
rna
extract
sampl
viral
prepar
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
extract
rna
along
known
amount
standard
rna
see
reversetranscrib
cdna
use
superscript
iii
system
invitrogen
oligodt
primer
quantit
copi
number
viral
genom
cdna
amplifi
use
viral
cdnaspecif
primer
thunderbird
qpcr
kit
toyobo
life
scienc
osaka
japan
amplif
proceed
cycl
denatur
anneal
extens
either
lightcycl
roch
appli
scienc
penzberg
germani
biorad
hercul
ca
usa
cdna
copi
number
deriv
fluoresc
signal
amplif
product
convert
particl
number
standard
rna
prepar
vitro
transcript
use
ribomax
express
larg
scale
rna
product
system
promega
templat
dna
pavic
v
gift
dr
albert
bosch
univers
barcelona
harbor
molecular
clone
infecti
titer
determin
use
method
describ
mendez
et
al
studi
infect
particl
per
cell
yield
approxim
cell
posit
antibodi
hpi
valu
multipl
infect
moi
calcul
approxim
prior
infect
confluent
cell
maintain
emem
wash
pb
thrice
starv
serum
h
incub
emem
supplement
sodium
pyruv
nonessenti
amino
acid
mm
hepe
stock
pretreat
trypsin
iv
catalog
sigmaaldrich
min
appli
cell
along
trypsin
approxim
particl
per
cell
mixtur
incub
h
intend
allow
viru
bind
cell
proceed
entri
process
note
procedur
describ
moser
schulzcherri
incub
h
substanti
alter
infecti
event
seen
incub
judg
number
cell
posit
viral
antigen
stain
mous
antibodi
data
shown
remov
cultur
medium
wash
incub
cell
continu
supplement
trypsin
iv
time
harvest
experi
involv
pharmacolog
inhibitor
infect
cell
carri
presenc
specifi
drug
design
time
period
ie
inhibitor
present
incub
viru
subsequ
iv
incub
genistein
jnk
inhibitor
ii
akt
inhibitor
v
triciribin
purchas
merck
whitehous
station
nj
usa
wortmannin
staurosporin
sigmaaldrich
obtain
promega
fitchburg
wi
usa
santa
cruz
biotechnolog
santa
cruz
ca
usa
selleckchem
houston
tx
usa
respect
drug
solubil
dimethyl
sulfoxid
dmso
initi
drug
concentr
select
consult
follow
refer
staurosporin
genistein
jnk
inhibitor
ii
wortmannin
triciribin
appropri
concentr
drug
determin
empir
examin
inhibitori
effect
infect
use
immunofluores
detect
viral
capsidposit
cell
addit
file
elisa
extent
viral
capsid
protein
releas
cell
infect
addit
file
infect
cell
fix
either
acetonemethanol
paraformaldehyd
pb
without
magnesium
calcium
pb
react
mous
antihastv
igg
catalog
santa
cruz
biotechnolog
pb
contain
goat
antimous
igg
conjug
alexafluor
catalog
invitrogen
use
secondari
antibodi
immunostain
cell
examin
epifluoresc
microscop
keyenc
osaka
japan
immunofluoresc
imag
prepar
use
adob
photoshop
adob
system
mountain
view
ca
usa
quantit
viral
infect
approxim
two
hundr
cell
count
least
three
differ
area
proport
capsidposit
cell
within
count
cell
use
statist
analysi
see
viabil
cell
infect
absenc
presenc
inhibitor
examin
use
cell
prolifer
assay
kit
cell
prolifer
assay
kit
takara
otsu
japan
base
cleavag
tetrazolium
salt
mitochondri
dehydrogenas
form
formazan
viabl
cell
design
dose
ad
cell
cultur
hpi
incub
continu
addit
h
cell
cultur
medium
measur
absorb
nm
versu
nm
refer
use
spectramax
micropl
reader
molecular
devic
sunnyval
ca
usa
protein
content
infect
cell
lysat
quantifi
either
bradford
method
takara
use
bca
protein
quantit
kit
thermo
fisher
scientif
waltham
usa
qubit
fluorometr
quantit
system
protein
invitrogen
cell
lysat
sampl
contain
amount
protein
separ
use
sdspolyacrylamid
gel
transfer
onto
pvdf
membran
probe
mapk
akt
use
specif
antibodi
primari
antibodi
obtain
cell
signal
beverli
usa
includ
follow
three
rabbit
antibodi
mapk
famili
antibodi
sampler
kit
catalog
mapk
clone
antisapkjnk
clone
mapk
three
rabbit
antibodi
phospho
mapk
famili
antibodi
sampler
kit
catalog
mapk
clone
mapk
clone
antiphosphosapkjnk
clone
rabbit
antiakt
antibodi
catalog
clone
antiphosphoakt
antibodi
catalog
clone
secondari
antibodi
rabbit
igg
conjug
horseradish
peroxidas
hrp
cell
signal
use
case
signal
detect
use
enzymelink
chemiluminesc
immunostar
wako
pure
chemic
industri
osaka
japan
expos
blot
xray
film
visual
band
membran
first
probe
phosphoryl
kinas
reprob
total
amount
kinas
restor
plu
western
blot
strip
buffer
thermo
fisher
scientif
waltham
usa
use
strip
antibodi
blot
chemiluminesc
signal
quantifi
densitometr
read
digit
imag
use
imagej
softwar
retriev
scan
xray
film
rna
purifi
infect
cell
use
nucleospin
rna
kit
machereynagel
germani
extract
rna
quantifi
use
spectrophotomet
thermo
fisher
scientif
fix
amount
total
rna
use
quantit
viral
rna
cultur
supernat
rna
purifi
condit
medium
collect
h
infect
use
qiaamp
viral
rna
mini
kit
qiagen
viral
rna
quantifi
use
onestep
sybr
primescript
plu
rtpcr
kit
primer
set
see
along
known
amount
vitro
transcrib
rna
standard
level
amplif
region
convert
quantiti
fulllength
viral
rna
cultur
supernat
infect
cell
examin
presenc
viral
capsid
elisa
brief
condit
medium
infect
cultur
appli
well
incub
overnight
microtit
plate
nuncimmuno
plate
maxisorp
thermo
fisher
scientif
wash
pb
contain
tween
incub
mous
antihastv
igg
block
solut
startingblock
block
buffer
tb
tween
catalog
thermo
fisher
scientif
h
wash
well
incub
dilut
hrpconjug
sheep
antimous
antibodi
ge
healthcar
waukesha
wi
usa
block
solut
h
follow
incub
hrpcolorimetr
substrat
tmb
microwel
peroxidas
substrat
system
catalog
kpl
gaithersburg
md
usa
room
temperatur
colorimetr
reaction
stop
use
tmb
stop
solut
catalog
kpl
absorb
measur
use
spectramax
micropl
reader
molecular
devic
anova
use
examin
statist
varianc
experiment
group
varianc
individu
set
data
examin
student
ttest
p
valu
consid
signific
indic
graph
author
declar
compet
interest
st
design
experi
wrote
manuscript
st
yz
yn
conduct
experi
ti
help
prepar
experi
author
read
approv
final
manuscript
